Worldwide Antimicrobial Susceptibility Patterns and Pharmacodynamic Comparisons of Gatifloxacin and Levofloxacin against Streptococcus pneumoniae: Report from the Antimicrobial Res...

Por Jones, Ronald N., Rubino, Christopher M., Bhavnani, Sujata M., Ambrose, Paul G.
Publicado em 2003

Comparison of Censored Regression and Standard Regression Analyses for Modeling Relationships between Antimicrobial Susceptibility and Patient- and Institution-Specific Variables

Por Hammel, Jeffrey P., Bhavnani, Sujata M., Jones, Ronald N., Forrest, Alan, Ambrose, Paul G.
Publicado em 2006

Association of Fluconazole Pharmacodynamics with Mortality in Patients with Candidemia

Por Baddley, John W., Patel, Mukesh, Bhavnani, Sujata M., Moser, Stephen A., Andes, David R.
Publicado em 2008

Use of Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Phase 2 and 3 Dosing Strategies for Doripenem

Por Bhavnani, Sujata M., Hammel, Jeffrey P., Cirincione, Brenda B., Wikler, Matthew A., Ambrose, Paul G.
Publicado em 2005

Evaluation of Daptomycin Exposure and Efficacy and Safety Endpoints To Support Risk-versus-Benefit Considerations

Por Bhavnani, Sujata M., Ambrose, Paul G., Hammel, Jeffrey P., Rubino, Christopher M., Drusano, George L.
Publicado no Antimicrob Agents Chemother (2016)

Pharmacokinetic-Pharmacodynamic Relationships Describing the Efficacy of Oritavancin in Patients with Staphylococcus aureus Bacteremia

Por Bhavnani, Sujata M., Passarell, Julie A., Owen, Joel S., Loutit, Jeffrey S., Porter, Steven B., Ambrose, Paul G.
Publicado em 2006

Relationship between Fosfomycin Exposure and Amplification of Escherichia coli Subpopulations with Reduced Susceptibility in a Hollow-Fiber Infection Model

Por VanScoy, Brian, McCauley, Jennifer, Bhavnani, Sujata M., Ellis-Grosse, Evelyn J., Ambrose, Paul G.
Publicado no Antimicrob Agents Chemother (2016)

Isoniazid Bactericidal Activity and Resistance Emergence: Integrating Pharmacodynamics and Pharmacogenomics To Predict Efficacy in Different Ethnic Populations

Por Gumbo, Tawanda, Louie, Arnold, Liu, Weiguo, Brown, David, Ambrose, Paul G., Bhavnani, Sujata M., Drusano, George L.
Publicado em 2007

Bacterial Replication Rate Modulation in Combination with Antimicrobial Therapy: Turning the Microbe against Itself

Por Ambrose, Paul G., VanScoy, Brian, Conde, Haley, McCauley, Jennifer, Rubino, Christopher M., Bhavnani, Sujata M.
Publicado no Antimicrob Agents Chemother (2016)

Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and Skin Structure Infections or Bacteremia

Por Rubino, Christopher M., Van Wart, Scott A., Bhavnani, Sujata M., Ambrose, Paul G., McCollam, Jill S., Forrest, Alan
Publicado em 2009

Tigecycline Population Pharmacokinetics in Patients with Community- or Hospital-Acquired Pneumonia

Por Rubino, Christopher M., Forrest, Alan, Bhavnani, Sujata M., Dukart, Gary, Cooper, Angel, Korth-Bradley, Joan, Ambrose, Paul G.
Publicado em 2010

Pharmacodynamic Evaluation of Factors Associated with the Development of Bacterial Resistance in Acutely Ill Patients during Therapy

Por Thomas, Jennifer K., Forrest, Alan, Bhavnani, Sujata M., Hyatt, Judith M., Cheng, Angela, Ballow, Charles H., Schentag, Jerome J.
Publicado em 1998

Pharmacokinetics-Pharmacodynamics of Gatifloxacin in a Lethal Murine Bacillus anthracis Inhalation Infection Model

Por Ambrose, Paul G., Forrest, Alan, Craig, William A., Rubino, Chistopher M., Bhavnani, Sujata M., Drusano, George L., Heine, Henry S.
Publicado em 2007

Frequentist and Bayesian Pharmacometric-Based Approaches To Facilitate Critically Needed New Antibiotic Development: Overcoming Lies, Damn Lies, and Statistics

Por Ambrose, Paul G., Hammel, Jeffrey P., Bhavnani, Sujata M., Rubino, Christopher M., Ellis-Grosse, Evelyn J., Drusano, George L.
Publicado em 2012

Clinical Pharmacodynamic Index Identification for Micafungin in Esophageal Candidiasis: Dosing Strategy Optimization

Por Andes, David R., Reynolds, Daniel K., Van Wart, Scott A., Lepak, Alexander J., Kovanda, Laura L., Bhavnani, Sujata M.
Publicado em 2013

Evaluation of the Pharmacokinetics and Pharmacodynamics of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infections Using Data from Two Pha...

Por Okusanya, Olanrewaju O., Bhavnani, Sujata M., Hammel, Jeffrey P., Forrest, Alan, Bulik, Catharine C., Ambrose, Paul G., Gupta, Renu
Publicado em 2014

Pharmacokinetics-Pharmacodynamics of Tigecycline in Patients with Community-Acquired Pneumonia

Por Rubino, Christopher M., Bhavnani, Sujata M., Forrest, Alan, Dukart, Gary, Dartois, Nathalie, Cooper, Angel, Korth-Bradley, Joan, Ambrose, Paul G.
Publicado em 2012

Pharmacodynamics of TD-1792, a Novel Glycopeptide-Cephalosporin Heterodimer Antibiotic Used against Gram-Positive Bacteria, in a Neutropenic Murine Thigh Model

Por Hegde, Sharath S., Okusanya, Olanrewaju O., Skinner, Robert, Shaw, Jeng-Pyng, Obedencio, Glenmar, Ambrose, Paul G., Blais, Johanne, Bhavnani, Sujata M.
Publicado em 2012

Application of an In Vitro Infection Model and Simulation for Reevaluation of Fluoroquinolone Breakpoints for Salmonella enterica Serotype Typhi

Por Booker, Brent M., Smith, Patrick F., Forrest, Alan, Bullock, Julie, Kelchlin, Pamela, Bhavnani, Sujata M., Jones, Ronald N., Ambrose, Paul G.
Publicado em 2005

Population Pharmacokinetics of Fusidic Acid: Rationale for Front-Loaded Dosing Regimens Due to Autoinhibition of Clearance

Por Bulitta, Jürgen B., Okusanya, Olanrewaju O., Forrest, Alan, Bhavnani, Sujata M., Clark, Kay, Still, J. Gordon, Fernandes, Prabhavathi, Ambrose, Paul G.
Publicado em 2013